Source: Zacks

GSK: GSK's Key Drugs to Drive Sales in a Sluggish Second Half

GSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up for the lower sales of established drugs due to generic erosion.

Read full article »
Annual Revenue
$42.3B
Employees
90,096
Dame Emma Walmsley's photo - CEO of GSK

CEO

Dame Emma Walmsley

CEO Approval Rating

66/100

Read more